Global Hereditary Angioedema Therapeutics Market Growth, Share, Size, Trends and Forecast (2021 - 2027)

Segmented by Drug Class;

C1 Esterase Inhibitor, Kallikrein Inhibitor, Bradykinin Receptor, Attenuated Androgens and Others.

Segmented by Route of Administration;

Subcutaneous, Intravenous and Oral.

Segmented by Distribution Channel;

Hospital Pharmacies, Retail Pharmacies and Online Pharmacies.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2017 - 2027).
Report ID: Rn157132041 Published Date: December, 2021 Updated Date: January, 2022

Introduction

Global Hereditary Angioedema Therapeutics Market (USD Million), 2017 - 2027

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2017 - 2027
2017 81.7
2018 94.2
2019 108.4
2020 113.1
2021 130.9
2022 144.3
2023 163.8
2024 184.9
2025 187.0
2026 214.5
2027 230.0

In the year 2020, the Global Hereditary Angioedema Therapeutics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2027, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Drug Class
    2. Market Snapshot, By Route of Administration
    3. Market Snapshot, By Distribution Channel
    4. Market Snapshot, By Region
    5. Market Opportunity Map
  4. Global Hereditary Angioedema Therapeutics Market
    1. Drivers, Restraints and Opportunities
      1. Drivers
      2. Restraints
      3. Opportunities
    2. Regulatory Scenario
    3. Pipeline Analysis/Technological Advancements
    4. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    5. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Hereditary Angioedema Therapeutics Market, By Drug Class, 2017 - 2027 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2021 and 2027 (%)
      3. Y-o-Y Growth Analysis, 2018 - 2027
      4. Segment Trends
        1. C1 Esterase Inhibitor
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
        2. Kallikrein Inhibitor
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
        3. Bradykinin Receptor
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
        4. Attenuated Androgens
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
        5. Others
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
    2. Global Hereditary Angioedema Therapeutics Market, By Route of Administration, 2017 - 2027 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2021 and 2027 (%)
      3. Y-o-Y Growth Analysis, 2018 - 2027
      4. Segment Trends
        1. Subcutaneous
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
        2. Intravenous
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
        3. Oral
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
    3. Global Hereditary Angioedema Therapeutics Market, By Distribution Channel, 2017 - 2027 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2021 and 2027 (%)
      3. Y-o-Y Growth Analysis, 2018 - 2027
      4. Segment Trends
        1. Hospital Pharmacies
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
        2. Retail Pharmacies
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
        3. Online Pharmacies
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2017 - 2027 (USD Million)
    4. Global Hereditary Angioedema Therapeutics Market, By Geography, 2017 - 2027 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2021 and 2027 (%)
      3. Y-o-Y Growth Analysis, 2018 - 2027
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
        4. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
        5. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2027 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2027 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2027 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. CSL Behring*
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. Shire Plc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Pharming Healthcare, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. BioCryst Pharmaceuticals, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Attune Pharmaceuticals, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      6. Arrowhead Pharmaceuticals
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      7. Adverum Biotechnologies
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market

ReAnIn's Most Viewed Titles:

Healthcare Medical Devices Hernia Repair Devices
Global Hernia Repair Devices and Consumables Market Growth, Share, Size, Trends and Forecast (2021 - 2027)

In the year 2020, the Global Hernia Repair Devices and Consumables Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2027, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Biotechnology High Content Screening
Global High Content Screening (HCS) Market Growth, Share, Size, Trends and Forecast (2021 - 2027)

In the year 2020, the Global High Content Screening (HCS) Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2027, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics High Potency Active Pharmaceutical Ingredients
Global High Potency Active Pharmaceutical Ingredients (APIs) Market Growth, Share, Size, Trends and Forecast (2021 - 2027)

In the year 2020, the Global High Potency Active Pharmaceutical Ingredients (APIs) Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2027, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Medical Devices High Resolution Melting Analysis
Global High Resolution Melting (HRM) Analysis Market Growth, Share, Size, Trends and Forecast (2021 - 2027)

In the year 2020, the Global High Resolution Melting (HRM) Analysis Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2027, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...